stella
beta
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis — Stella
Recruiting
Back to Multiple Sclerosis trials
Trial locations
(109 sites)
Germany
Novartis Investigative Site, Albstadt, Baden-Wurttemberg
Novartis Investigative Site, Hettingen, Baden-Wurttemberg
Novartis Investigative Site, Mannheim, Baden-Wurttemberg
Novartis Investigative Site, Schwetzingen, Baden-Wurttemberg
Novartis Investigative Site, Bamberg, Bavaria
Show all 109 locations
View full record on ClinicalTrials.gov